Tarsus Pharmaceuticals
TARS
#4041
Rank
โ‚น265.89 B
Marketcap
โ‚น6,248
Share price
-1.41%
Change (1 day)
43.95%
Change (1 year)

Revenue for Tarsus Pharmaceuticals (TARS)

Revenue in 2025 (TTM): โ‚น39.65 Billion

According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น42.56 Billion. an increase over the revenue in the year 2024 that were of โ‚น15.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tarsus Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น40.51 B158.16%
2024 โ‚น15.69 B980.59%
2023 โ‚น1.45 B-32.01%
2022 โ‚น2.13 B-49.67%
2021 โ‚น4.24 B
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA